Table 2.
QT/QTc mean durations in the sample and in treatment groups.
| Atypical neuroleptic | QT | QTc |
|---|---|---|
| 2Clozapine (n = 14) | 361.1 ± 22.4 | 399.3 ± 11.0 |
| Olanzapine (n = 13) | 364.5 ± 36.9 | 393.6 ± 20.5 |
| Risperidone (n = 12) | 371.8 ± 27.3 | 403.1 ± 16.6 |
| 1Aripiprazole (n = 15) | 349.0 ± 28.3 | 391.7 ± 23.2 |
| Quetiapine (n = 43) | 370.6 ± 21.8 | 401.3 ± 14.8 |
| 1,2Paliperidone (n = 12) | 390.5 ± 29.8 | 411.4 ± 20.3 |
| Overall sample (n = 109) | 368.0 ± 28.0 | 400.1 ± 17.8 |
Kruskal-Wallis Test, followed by a Dunn Test for pairwise post hoc comparisons; 1QT paliperidone > QT aripiprazole: p = .004; 2QT paliperidone > QT clozapine: p = .033.